Clinical Trial Update: PMCF Study for PROFEMUR® Am Femoral Components and PROCOTYL® O HA Coated Acetabular Components

View source ↗

Summary

A Post-Market Clinical Follow-up (PMCF) study evaluating the PROFEMUR Am Femoral Components and PROCOTYL O HA Coated Acetabular Components has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Joint Disease

Snippet

Sponsor: MicroPort Orthopedics Inc. | Conditions: Joint Disease | Status: WITHDRAWN